Plain-English translation of NCT05936073 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This is a research study looking at hepatitis D infection in France. Researchers want to understand how many people are being tested for this virus, who is getting tested, and what happens to patients who test positive. By collecting information from hospitals, labs, and insurance records, they hope to find ways to make testing and treatment easier to access.
Hepatitis D is a serious liver disease that can lead to cirrhosis and liver cancer, and new treatments are now available. However, in France there is very little data about how many people are being tested, who is diagnosing them, and whether patients can access care. This study aims to fill those gaps and identify barriers to better screening and treatment.
You likely qualify if…
You likely don't qualify if…
This is not an active treatment study. Instead, researchers will review existing medical records and testing data from hospitals, private labs, and health insurance companies across France from 2016 to 2020. If you test positive for hepatitis D, your doctors may share anonymized information about your test results and medical care with the research team, but you won't need to attend special visits or receive new treatment.
AI-generated summary from trial data · Jun 27, 2026 · Not medical advice
France
Enrollment target
~734 participants
Started
January 2024
Primary completion
June 2025
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
18 Years and older
Last updated on clinicaltrials.gov in May 2025.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Sandra Juge
University Hospital, Limoges
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.